[HMG-CoA reductase inhibitors (statin)].
Yamamura
Taku
T
Division of Health Sciences, Osaka University Graduate School of Medicine.
Ishigami
Masato
M
D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use*